GL1X · GenesisL1 explorer

Research workbench

A novel anti-adipogenic partial agonist of peroxisome proliferator- activated receptor-gamma (pparg) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro

Analyse A novel anti-adipogenic partial agonist of peroxisome proliferator- activated… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2FVJ
Type
protein
Length
268 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma; Nuclear receptor coactivator 1
EC
2.3.1.48
UniProt
P37231, Q15788
Ligands
RO0
Pockets
2 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25867% helix, 5% strandP37231
BNuclear receptor coactivator 1 (EC 2.3.1.48)protein1070% helix, 0% strandQ15788

Ligands and binding sites

  • RO0 · 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-4-{[4-(2-methoxyphenyl)piperidin-1-yl]methyl}isoquinoline · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15630.810.8654RO0, GOL
2880.450.8015empty

Interfaces

1 interface between chains.

  • A–B · 515 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 2FVJ · A novel anti-adipogenic partial agonist of peroxisome proliferator-activated… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.